These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 2675000

  • 1. Multicenter study of the BCG Tokyo strain for intravesical treatment in patients with superficial bladder cancer. BCG Study Group.
    Aso Y, Akaza H, Kameyama S, Niijima T.
    Prog Clin Biol Res; 1989; 303():383-91. PubMed ID: 2675000
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Bacillus Calmette-Guérin and superficial bladder cancer. Clinical experience and mechanism of action.
    Catalona WJ, Ratliff TL.
    Surg Annu; 1990; 22():363-78. PubMed ID: 2408170
    [No Abstract] [Full Text] [Related]

  • 10. Mitomycin-C and BCG in intravesical chemotherapy and immunotherapy of superficial bladder cancer. Finnbladder Research Group.
    Rintala E, Jauhiainen K, Alfthan O.
    Prog Clin Biol Res; 1989; 310():271-4. PubMed ID: 2505270
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Long-term effect of intravesical bacillus Calmette-Guérin (BCG) Tice strain on flat carcinoma in situ of the bladder.
    Reitsma DJ, Guinan P, Lamm DL, Khanna OP, Brosma SA, DeKernion JB, Williams RD, Sipmson G, Hanna MG.
    Prog Clin Biol Res; 1989; 310():171-85. PubMed ID: 2672014
    [No Abstract] [Full Text] [Related]

  • 16. [Low-dose BCG in the therapy of superficial neoplasms of the bladder].
    Francesco Bassi P, Milani C, Meneghini A, Maruzzi D, Garbeglio A, Aragona F, Tejerizo JC, Pagano F.
    Arch Esp Urol; 1990 Jun; 43(5):503-7. PubMed ID: 2202264
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Intravesical Bacillus Calmette-Guerin (BCG: Tokyo 172 strain) instillation for carcinoma in situ of the bladder: results with 6 successive instillations of 40 mg BCG].
    Mugiya S, Nagata M, Takayama T, Ozono S, Ito T, Maruyama S, Hadano S, Nagae H.
    Hinyokika Kiyo; 2004 Jul; 50(7):469-73. PubMed ID: 15334890
    [Abstract] [Full Text] [Related]

  • 19. [Intravesical BCG vaccine in bladder cancer].
    Beisland HO, Sander S.
    Tidsskr Nor Laegeforen; 1989 Jun 20; 109(17-18):1891-2. PubMed ID: 2749672
    [Abstract] [Full Text] [Related]

  • 20. BCG in the management of superficial bladder cancer.
    Guinan P, Richardson C, Hanna M, Rubenstein M.
    Prog Clin Biol Res; 1989 Jun 20; 303():447-53. PubMed ID: 2675002
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.